REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $0 | -100.0% | 134 | -96.3% | 0.00% | – |
Q3 2015 | $2,000 | -50.0% | 3,619 | -49.6% | 0.00% | – |
Q2 2015 | $4,000 | -20.0% | 7,179 | +2.6% | 0.00% | – |
Q1 2015 | $5,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
Q4 2014 | $5,000 | -16.7% | 7,000 | 0.0% | 0.00% | – |
Q3 2014 | $6,000 | -45.5% | 7,000 | -45.6% | 0.00% | – |
Q2 2014 | $11,000 | -31.2% | 12,874 | -13.1% | 0.00% | – |
Q1 2014 | $16,000 | +166.7% | 14,822 | +46.2% | 0.00% | – |
Q4 2013 | $6,000 | +100.0% | 10,135 | +44.8% | 0.00% | – |
Q3 2013 | $3,000 | 0.0% | 7,000 | -5.1% | 0.00% | – |
Q2 2013 | $3,000 | – | 7,380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |